These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2162397)

  • 61. Epstein-Barr virus antibodies in serum and DNA load in saliva are not associated with radiological or clinical disease activity in patients with early multiple sclerosis.
    Gieß RM; Pfuhl C; Behrens JR; Rasche L; Freitag E; Khalighy N; Otto C; Wuerfel J; Brandt AU; Hofmann J; Eberspächer B; Bellmann-Strobl J; Paul F; Ruprecht K
    PLoS One; 2017; 12(4):e0175279. PubMed ID: 28388676
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Viral infection and its causative role for chronic fatigue syndrome].
    Okano M
    Nihon Rinsho; 1992 Nov; 50(11):2617-24. PubMed ID: 1337559
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches.
    Diaz-Mitoma F; Vanast WJ; Tyrrell DL
    Lancet; 1987 Feb; 1(8530):411-5. PubMed ID: 2880216
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A chronic "postinfectious" fatigue syndrome associated with benign lymphoproliferation, B-cell proliferation, and active replication of human herpesvirus-6.
    Buchwald D; Freedman AS; Ablashi DV; Sullivan JL; Caligiuri M; Weinberg DS; Hall CG; Ashley RL; Saxinger C; Balachandran N
    J Clin Immunol; 1990 Nov; 10(6):335-44. PubMed ID: 1964694
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
    Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
    Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y
    AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Fatigue and herpesvirus latency in women newly diagnosed with breast cancer.
    Fagundes CP; Glaser R; Alfano CM; Bennett JM; Povoski SP; Lipari AM; Agnese DM; Yee LD; Carson WE; Farrar WB; Malarkey WB; Kiecolt-Glaser JK
    Brain Behav Immun; 2012 Mar; 26(3):394-400. PubMed ID: 21988771
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
    Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
    Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The differential impact of training stress and final examination stress on herpesvirus latency at the United States Military Academy at West Point.
    Glaser R; Friedman SB; Smyth J; Ader R; Bijur P; Brunell P; Cohen N; Krilov LR; Lifrak ST; Stone A; Toffler P
    Brain Behav Immun; 1999 Sep; 13(3):240-51. PubMed ID: 10469525
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnostic Performance and Comparative Evaluation of the Architect, Liaison, and Platelia Epstein-Barr Virus Antibody Assays.
    Park Y; Park BG; Ha J; Kim HS
    Ann Lab Med; 2018 Sep; 38(5):458-465. PubMed ID: 29797817
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up.
    Lerner AM; Beqaj SH; Deeter RG; Fitzgerald JT
    In Vivo; 2007; 21(5):707-13. PubMed ID: 18019402
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Studies of herpesvirus infection in chronic fatigue syndrome.
    Straus SE
    Ciba Found Symp; 1993; 173():132-9; discussion 139-45. PubMed ID: 8387907
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
    Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
    Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Epstein-Barr antibody titer and chronic fatigue syndrome.
    Powell MA
    J Am Acad Nurse Pract; 1990; 2(1):33-4. PubMed ID: 2158339
    [No Abstract]   [Full Text] [Related]  

  • 76. Loneliness predicts pain, depression, and fatigue: understanding the role of immune dysregulation.
    Jaremka LM; Fagundes CP; Glaser R; Bennett JM; Malarkey WB; Kiecolt-Glaser JK
    Psychoneuroendocrinology; 2013 Aug; 38(8):1310-7. PubMed ID: 23273678
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Review of laboratory findings for patients with chronic fatigue syndrome.
    Buchwald D; Komaroff AL
    Rev Infect Dis; 1991; 13 Suppl 1():S12-8. PubMed ID: 1902321
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The existence of a fatigue syndrome after glandular fever.
    White PD; Thomas JM; Amess J; Grover SA; Kangro HO; Clare AW
    Psychol Med; 1995 Sep; 25(5):907-16. PubMed ID: 8588009
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chronic fatigue syndrome in northern Nevada.
    Daugherty SA; Henry BE; Peterson DL; Swarts RL; Bastien S; Thomas RS
    Rev Infect Dis; 1991; 13 Suppl 1():S39-44. PubMed ID: 1850542
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Molecular approaches to epidemiologic evaluation of viruses as risk factors for patients who have chronic fatigue syndrome.
    Miller G
    Rev Infect Dis; 1991; 13 Suppl 1():S119-22. PubMed ID: 1850537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.